8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
Pooled results from many studies on one question.
2021 / Systematic review and dose-response meta-analysis
A systematic review and dose-response meta-analysis evaluated 14 studies with over 34,000 participants across 17 countries to assess chronic mercury exposure and CVD outcomes. Mercury exposure was associated with increases in nonfatal ischemic heart disease (RR 1.21; 95% CI 0.98, 1.50), all-cause mortality (RR 1.21; 95% CI 0.90, 1.62), CVD mortality (RR 1.68; 95% CI 1.15, 2.45), and mortality from other heart diseases (RR 1.50; 95% CI 1.07, 2.11), but not stroke. A J-shaped relationship was observed, with turning points at hair mercury concentrations of 1 μg/g for IHD and 2 μg/g for stroke and all CVD.
Shows an association, not proof of cause and effect.
Hu XF, Lowe M, Chan HM Environ Res, 2021. PMID 33285155
2021 / Systematic review and meta-analysis of cohort studies
A meta-analysis of 24 studies examined long-term mortality in former elite athletes categorized by endurance, mixed/team, or power sports. Former athletes lived significantly longer than the general population (male SMR 0.69 [95% CI 0.61-0.78]; female SMR 0.51 [95% CI 0.40-0.65]; both p < 0.01), though no survival benefit was observed for male power athletes (SMR 1.04 [95% CI 0.91-1.12]). Male athletes had significantly reduced CVD mortality (SMR 0.73 [95% CI 0.62-0.85]) and cancer mortality (SMR 0.75 [95% CI 0.63-0.89]), but risk reductions were not seen for power athletes' CVD mortality or endurance athletes' cancer mortality. Data were insufficient to calculate female sport-specific SMRs.
Shows an association, not proof of cause and effect.
Runacres A, Mackintosh KA, McNarry MA Sports Med, 2021. PMID 33368029
2021 / Umbrella review of systematic reviews and meta-analyses
An umbrella review examined 41 meta-analyses with 45 unique health outcomes in humans to evaluate the evidence on milk intake. Dose-response analyses indicated that a 200 ml per day increment in milk intake was linked to a lower risk of cardiovascular disease, stroke, hypertension, colorectal cancer, metabolic syndrome, obesity, and osteoporosis, with beneficial associations also observed for type 2 diabetes mellitus and Alzheimer's disease. Conversely, milk intake was associated with a higher risk of prostate cancer, Parkinson's disease, acne, and iron-deficiency anemia in infancy, with caution noted for potential allergy or lactose intolerance.
Shows an association, not proof of cause and effect.
Zhang X, Chen X, Xu Y, et al. Nutr Metab (Lond), 2021. PMID 33413488
2021 / Systematic review and meta-analysis of randomized clinical trials
A systematic review and meta-analysis evaluated 23 randomized trials (1,357 participants) testing low (<130 g/day or <26% energy) and very low (<10% energy) carbohydrate diets (LCDs and VLCDs) for at least 12 weeks in adults with type 2 diabetes. At six months, LCDs achieved higher rates of diabetes remission defined as HbA1c <6.5% compared to control diets (57% vs 31%; risk difference 0.32, 95% CI 0.17 to 0.47), though effect sizes were smaller and non-significant when remission was defined as HbA1c <6.5% without medication. Clinically important improvements in weight loss, triglycerides, and insulin sensitivity at six months diminished by 12 months, and data on 12-month remission were sparse. At 12 months, participants experienced clinically important but not statistically significant worsening of quality of life and LDL cholesterol.
Goldenberg JZ, Day A, Brinkworth GD, et al. BMJ, 2021. PMID 33441384
2021 / Dose-response meta-analysis of prospective studies
A dose-response meta-analysis of prospective studies evaluated caffeinated coffee intake and select health outcomes. In any coffee consumers, there was a significant inverse association with the risk of CVD (RR = 0.90; 95% CI: 0.84, 0.96), T2D (RR = 0.90; 95% CI: 0.85, 0.96), endometrial cancer (RR = 0.85; 95% CI: 0.78, 0.92), melanoma (RR = 0.89; 95% CI: 0.80, 0.99), and nonmelanoma skin cancer (RR = 0.92; 95% CI: 0.89, 0.95). Consumption was also inversely associated with HCC without reaching statistical significance (RR = 0.93; 95% CI: 0.80, 1.08). The dose-response relation was nonlinear uniquely for CVD (P-nonlinearity = 0.01), with the largest risk reduction observed for 3-4 cups/d and no reduction thereafter, whereas risk decreased linearly for other outcomes.
Shows an association, not proof of cause and effect.
Di Maso M, Boffetta P, Negri E, et al. Adv Nutr, 2021. PMID 33570108
2021 / Systematic review
A systematic review of 211 articles evaluated the effect of industry funding on cholesterol research related to egg ingestion. Net cholesterol increases were reported in 93% of non-industry-funded and 86% of industry-funded intervention studies, while no studies reported significant cholesterol decreases. Despite these findings, 49% of industry-funded intervention studies reported conclusions discordant with results (describing net cholesterol increases as favorable), compared with 13% of non-industry-funded studies.
Barnard ND, Long MB, Ferguson JM, et al. Am J Lifestyle Med, 2021. PMID 33786032
2021 / Umbrella review of meta-analyses of randomized controlled trials
An umbrella review analyzed meta-analyses of randomized controlled trials examining resveratrol supplementation compared to control groups in patients with type 2 diabetes, metabolic syndrome, and NAFLD. While resveratrol showed beneficial effects on some markers (such as blood pressure, lipids, glycemic control, and waist circumference), the magnitude of effect was generally trivial, evidence certainty was very low to low, or trials were too few. Resveratrol showed a clinically important short-term (<12 weeks) reduction in HbA1c (mean difference: -1.05%, 95% CI: -2.09% to -0.02%; n = 6; moderate certainty), though evidence overall does not support supplementation for cardiometabolic management.
Zeraattalab-Motlagh S, Jayedi A, Shab-Bidar S Am J Clin Nutr, 2021. PMID 34320173
2021 / Systematic review and meta-analysis
A systematic review and meta-analysis of 42 studies with 423,117 patients assessed clinical risk factors associated with COVID-19 mortality. The pooled prevalence of mortality among hospitalized patients was 17.62% (95% CI 14.26-21.57%). Increased mortality risk was linked to older age (pOR 2.61, pHR 1.31), male sex (pOR 1.45, pHR 1.24), and current smoking status (pOR 1.42). Obesity, acute kidney injury, chronic obstructive pulmonary disease, cardiovascular disease, diabetes, hypertension, cancer, and increased D-dimer were also reported as clinical risk factors for fatal outcomes.
Shows an association, not proof of cause and effect.
Dessie ZG, Zewotir T BMC Infect Dis, 2021. PMID 34418980
2021 / Systematic review and dose-response meta-analysis of RCTs
Researchers conducted a systematic review and dose-response meta-analysis of randomized controlled trials to evaluate the effects of artichoke on lipid profiles. Combining 15 effect sizes from 14 studies, artichoke significantly reduced triglycerides (WMD: -17.01 mg/dl, 95% CI: -23.88, -10.13, p = .011), total cholesterol (WMD: -17.01 mg/dl, 95% CI: -23.88, -10.13, p < .001), and LDL-C (WMD: -17.48 mg/dl, 95% CI: -25.44, -9.53, p < .001), with no significant effect on HDL-C (WMD: 0.78 mg/dl, p = .371). Artichoke juice specifically (two effect sizes) significantly lowered triglycerides, total cholesterol, LDL-C, and HDL-C levels.
Shahinfar H, Bazshahi E, Amini MR, et al. Phytother Res, 2021. PMID 34569671
2021 / Systematic review and meta-analysis of prospective cohort studies
A systematic review and meta-analysis of seven prospective cohort studies evaluated the risk of incident stroke among vegetarians compared to nonvegetarians. Adherence to vegetarian diets showed no significant association with incident stroke risk (HR = 0.86; 95% CI = 0.67-1.11; I2 = 68%, n = 7). Similarly, no significant associations were found for ischemic stroke (HR = 0.56; 95% CI = 0.22-1.42; I2 = 82%, n = 3) or hemorrhagic stroke (HR = 0.77; 95% CI = 0.19-3.09; I2 = 85%, n = 2). Subgroup analyses suggested lower stroke risk among vegetarians in studies from Asia and in participants with a mean baseline age of 50-65 years, though overall certainty of evidence was limited by NutriGrade.
Shows an association, not proof of cause and effect.
Lu JW, Yu LH, Tu YK, et al. Nutrients, 2021. PMID 34578897
2021 / Systematic review and meta-analysis of randomized controlled trials
A systematic review and meta-analysis of five randomized controlled trials including 230 subjects evaluated the effect of Spirulina (1 to 8 g per day for 2 to 12 weeks) on blood pressure. Spirulina supplementation resulted in a significant lowering of systolic blood pressure (MD: -4.59 mmHg, 95% CI: -8.20 to -0.99, I2 = 65%) and diastolic blood pressure (MD: -7.02 mmHg, 95% CI: -8.86 to -5.18, I2 = 11%), especially in a subgroup of hypertensive patients. Authors note that more exact randomized controlled trials are needed to clarify these effects.
Machowiec P, Ręka G, Maksymowicz M, et al. Nutrients, 2021. PMID 34578932
2021 / Systematic review
A systematic review of 13 studies assessed the effects of endurance, resistance, coordinative, and multimodal exercise on resting heart rate variability (HRV) and cardiovascular health factors in healthy older adults. The majority of studies showed significant positive effects on cardiac autonomic control, except for resistance training interventions. All exercise modalities led to improvements in secondary health factors. The authors noted that future studies need to better adhere to methodological standards for exercise interventions and ECG recording.
Grässler B, Thielmann B, Böckelmann I, et al. Eur Rev Aging Phys Act, 2021. PMID 34789148
2020 / Meta-analysis of prospective cohort studies
A meta-analysis evaluated 20 prospective cohort studies assessing potato consumption and mortality risk. No significant associations were observed for all-cause mortality (0.90, 95% CI: 0.80 to 1.02, p = 0.096; 25,208 cases) or cancer mortality (1.09, 95% CI: 0.96 to 1.24, P = 0.204; 4,877 cases). Among three studies examining cardiovascular mortality (2,366 cases), two found no significant relationship.
Shows an association, not proof of cause and effect.
Darooghegi Mofrad M, Milajerdi A, Sheikhi A, et al. Crit Rev Food Sci Nutr, 2020. PMID 30638040
2020 / Systematic review and dose-response meta-analysis
A meta-analysis analyzed 8 studies comprising 11,750 individuals and 6,176 hypertensive cases. High circulating TMAO levels were associated with greater hypertension prevalence compared to low levels (RR: 1.12; 95% CI: 1.06, 1.17; P < 0.0001). In dose-response models, the relative risk of hypertension rose by 9% for each 5-μmol/L rise (RR: 1.09; 95% CI: 1.05, 1.14) and 20% for each 10-μmol/L rise in blood TMAO (RR: 1.20; 95% CI: 1.11, 1.30).
Ge X, Zheng L, Zhuang R, et al. Adv Nutr, 2020. PMID 31269204
2020 / Systematic review and meta-analysis of observational studies
A systematic review and meta-analysis of 48 studies examined the link between high amounts of physical activity and mortality in the general population. Compared with the recommended level of 750 MET min/week, mortality risk was lower at physical activity levels exceeding recommendations up to at least 5000 MET min/week for all-cause mortality (HR=0.86, 95% CI 0.78 to 0.94) and CVD mortality (HR=0.73, 95% CI 0.56 to 0.95). There was no threshold observed beyond which lifespan was compromised. Limitations reported include the observational nature of the included studies and inaccurate estimations of physical activity amounts.
Shows an association, not proof of cause and effect.
Blond K, Brinkløv CF, Ried-Larsen M, et al. Br J Sports Med, 2020. PMID 31406017
2020 / Systematic review and meta-analysis of randomized controlled trials
A systematic review and meta-analysis summarized findings from randomized controlled trials examining regular dietary olive oil consumption. Olive oil intake reduced levels of inflammatory markers, particularly interleukin-6, C-reactive protein, and tumor necrosis factor-alpha. The authors noted that additional research comparing olive oil to other dietary fats is still needed, accounting for varying daily dosages and intervention durations.
NANO counterpoint →
Fernandes J, Fialho M, Santos R, et al. Nutrition, 2020. PMID 31539817
2020 / Systematic review
This systematic review examined 8 studies (5 human crossover studies and 3 animal studies) published between 2009 and 2016 to investigate the effect of mouth rinse use on nitrate/nitrite levels and blood pressure. In human studies comparing antibacterial mouth rinses to control, 5 of 5 reported reduced salivary nitrite, 3 of 5 reported reduced plasma nitrite, and 4 of 5 observed increased blood pressure. In animal studies, 2 of 3 reported reduced plasma nitrite and increased blood pressure compared to control. Differential effects were observed depending on mouth rinse strength and composition.
Senkus KE, Crowe-White KM Crit Rev Food Sci Nutr, 2020. PMID 31542940
2020 / Meta-analysis of interventional studies
A meta-analysis evaluated six interventional studies involving 317 patients with type 2 diabetes mellitus to assess glycemic control. Vinegar consumption significantly improved fasting blood glucose and hemoglobin A1c levels. Secondary outcomes revealed reductions in total cholesterol and low-density lipoprotein. The authors noted that sample sizes were relatively small and vinegar formulations varied.
Cheng LJ, Jiang Y, Wu VX, et al. J Adv Nurs, 2020. PMID 31667860
2020 / Systematic review and meta-analysis of RCTs
A meta-analysis of 32 randomised controlled trials evaluated dietary anthocyanins on inflammatory markers. Anthocyanin supplementation significantly reduced C-reactive protein (-0.33 mg/l, 95% CI: -0.55 to -0.11), IL-6 (-0.41 ρg/ml, 95% CI: -0.70 to -0.13), TNF-α (-0.64 ρg/ml, 95% CI: -1.18 to -0.09), ICAM-1 (-52.4 ng/ml, 95% CI: -85.7 to -19.1), and VCAM-1 (-49.6 ng/ml, 95% CI: -72.7 to -26.5), while increasing adiponectin (0.75 μg/ml, 95% CI: 0.23 to 1.26). Interleukin-1β and P-selectin did not significantly change.
Fallah AA, Sarmast E, Fatehi P, et al. Food Chem Toxicol, 2020. PMID 31669599
2020 / Systematic review and meta-analysis
A systematic review and meta-analysis of 26 studies assessed pet ownership in relation to cardiovascular outcomes and mortality. Pet ownership was associated with lower cardiovascular mortality (adjusted HR 0.81, 95% CI 0.68-0.97), while the adjusted HR for overall mortality was 0.40 (95% CI 0.04-3.78). Cat ownership was associated with reduced cardiovascular mortality (adjusted HR 0.79, 95% CI 0.63-0.99), but dog ownership showed no significant association with overall or cardiovascular mortality. Pet owners had significantly lower heart rate (mean difference -2.32 bpm, 95% CI -3.07 to -1.57), mean arterial pressure (-2.60 mmHg, 95% CI -4.25 to -0.95), and systolic blood pressure (-1.69 mmHg, 95% CI -3.06 to -0.31), with no significant differences in diastolic blood pressure or hypertension prevalence.
Shows an association, not proof of cause and effect.
El-Qushayri AE, Kamel AMA, Faraj HA, et al. J Cardiovasc Med (Hagerstown), 2020. PMID 31815850
2020 / Systematic review and dose-response meta-analysis of RCTs
A systematic review and dose-response meta-analysis of 62 RCTs with 3,772 participants examined the effects of flaxseed supplementation on blood lipid profiles. Flaxseed significantly reduced total cholesterol (WMD = -5.389 mg/dL; 95% CI: -9.483, -1.295, p = 0.010), triglycerides (WMD = -9.422 mg/dL; 95% CI: -15.514, -3.330, p = 0.002), and LDL-C (WMD = -4.206 mg/dl; 95% CI: -7.260, -1.151, p = 0.007). It had no significant effect on HDL-C (WMD = 0.047 mg/dl; 95% CI: -0.777, 0.872, p = 0.910). The authors noted that large-scale studies with better design are needed to confirm the results.
Hadi A, Askarpour M, Salamat S, et al. Pharmacol Res, 2020. PMID 31899314
2020 / Systematic review and dose-response meta-analysis of RCTs
A systematic review and meta-analysis of eight randomized controlled trials evaluated the effects of psyllium in 395 diabetic participants. Psyllium consumption led to significant reductions in triglycerides (WMD: -19.18 mg/dl, 95% CI [-31.76, -6.60]), low-density lipoprotein (WMD: -8.96 mg/dl, 95% CI [-13.39, -4.52]), fasting blood sugar (WMD: -31.71 ml/dl, 95% CI [-50.04, -13.38]), and hemoglobin A1c (WMD: -0.91%, 95% CI [-1.31, -0.51]). There were no significant changes in high-density lipoprotein, body mass index, cholesterol, or weight.
Xiao Z, Chen H, Zhang Y, et al. Phytother Res, 2020. PMID 31919936
2020 / Meta-analysis of randomized controlled trials
A meta-analysis of seven randomized controlled trials evaluated the efficacy of red yeast rice (RYR) extract in 10,699 myocardial infarction patients with borderline hypercholesterolemia. RYR extract (1,200 mg/day) reduced nonfatal MI (RR = 0.42, 95% CI 0.34 to 0.52), revascularization (RR = 0.58, 95% CI 0.48 to 0.71), and sudden death (RR = 0.71, 95% CI 0.53 to 0.94). It also lowered LDL (WMD = -20.70 mg/dL), TC (WMD = -26.61 mg/dL), and TG (WMD = -24.69 mg/dL), while increasing HDL levels (WMD = 2.71 mg/dL). Study follow-ups ranged from 4 weeks to 4.5 years, and studies were assessed as overall high quality with low risk of bias.
Sungthong B, Yoothaekool C, Promphamorn S, et al. Sci Rep, 2020. PMID 32066811
2020 / Prospective cohort and meta-analysis of prospective cohorts
In the Rotterdam Study (7,786 participants, median follow-up 13.0 years, 3,589 deaths), higher total protein intake was associated with greater all-cause mortality (HR 1.12, 95% CI 1.01-1.25), largely driven by animal protein and CVD deaths. A meta-analysis of 11 cohorts (350,452 participants, 64,306 deaths) confirmed higher all-cause mortality with total protein (pooled RR 1.05, 95% CI 1.01-1.10). Plant protein was associated with reduced all-cause (RR 0.93, 95% CI 0.87-0.99) and CVD mortality (RR 0.86, 95% CI 0.73-1.00).
Shows an association, not proof of cause and effect.
Chen Z, Glisic M, Song M, et al. Eur J Epidemiol, 2020. PMID 32076944